150 related articles for article (PubMed ID: 29424557)
21. CD24, a novel cancer biomarker, predicting disease-free survival of non-small cell lung carcinomas: a retrospective study of prognostic factor analysis from the viewpoint of forthcoming (seventh) new TNM classification.
Lee HJ; Choe G; Jheon S; Sung SW; Lee CT; Chung JH
J Thorac Oncol; 2010 May; 5(5):649-57. PubMed ID: 20354454
[TBL] [Abstract][Full Text] [Related]
22. GAB2 Amplification in Squamous Cell Lung Cancer of Non-Smokers.
Park YR; Bae SH; Ji W; Seo EJ; Lee JC; Kim HR; Jang SJ; Choi CM
J Korean Med Sci; 2017 Nov; 32(11):1784-1791. PubMed ID: 28960030
[TBL] [Abstract][Full Text] [Related]
23. High ECT2 expression is an independent prognostic factor for poor overall survival and recurrence-free survival in non-small cell lung adenocarcinoma.
Zhou S; Wang P; Su X; Chen J; Chen H; Yang H; Fang A; Xie L; Yao Y; Yang J
PLoS One; 2017; 12(10):e0187356. PubMed ID: 29088286
[TBL] [Abstract][Full Text] [Related]
24. Downregulation of HOXA3 in lung adenocarcinoma and its relevant molecular mechanism analysed by RT-qPCR, TCGA and in silico analysis.
Gan BL; He RQ; Zhang Y; Wei DM; Hu XH; Chen G
Int J Oncol; 2018 Oct; 53(4):1557-1579. PubMed ID: 30066858
[TBL] [Abstract][Full Text] [Related]
25. A typical presentation of primary pulmonary epithelioid sarcoma misdiagnosed as non-small cell lung cancer.
Emori M; Tamakawa M; Kaya M; Takada K; Murase K; Fujita C; Sato S; Takahashi R; Hatanaka KC; Sugita S; Hirano H; Yamashita T; Hasegawa T
Pathol Int; 2017 Apr; 67(4):222-224. PubMed ID: 28078765
[No Abstract] [Full Text] [Related]
26. Proteomics biomarkers for non-small cell lung cancer.
Kisluk J; Ciborowski M; Niemira M; Kretowski A; Niklinski J
J Pharm Biomed Anal; 2014 Dec; 101():40-9. PubMed ID: 25175018
[TBL] [Abstract][Full Text] [Related]
27. Rapid biomarker testing for improved clinical decision-making in nonsmall cell lung cancer.
Kaplan EH
MLO Med Lab Obs; 2017 Jun; 49(6):12-4, 16-8. PubMed ID: 29952196
[No Abstract] [Full Text] [Related]
28. Quantitative Proteomic Analysis of Optimal Cutting Temperature (OCT) Embedded Core-Needle Biopsy of Lung Cancer.
Zhao X; Huffman KE; Fujimoto J; Canales JR; Girard L; Nie G; Heymach JV; Wistuba II; Minna JD; Yu Y
J Am Soc Mass Spectrom; 2017 Oct; 28(10):2078-2089. PubMed ID: 28752479
[TBL] [Abstract][Full Text] [Related]
29. Integrated quantitative proteomic and transcriptomic analysis of lung tumor and control tissue: a lung cancer showcase.
Tenzer S; Leidinger P; Backes C; Huwer H; Hildebrandt A; Lenhof HP; Wesse T; Franke A; Meese E; Keller A
Oncotarget; 2016 Mar; 7(12):14857-70. PubMed ID: 26930711
[TBL] [Abstract][Full Text] [Related]
30. Clinical value of miR-198-5p in lung squamous cell carcinoma assessed using microarray and RT-qPCR.
Liang YY; Huang JC; Tang RX; Chen WJ; Chen P; Cen WL; Shi K; Gao L; Gao X; Liu AG; Peng XT; Chen G; Huang SN; Fang YY; Gu YY
World J Surg Oncol; 2018 Feb; 16(1):22. PubMed ID: 29394946
[TBL] [Abstract][Full Text] [Related]
31. [IHC, FISH, CISH, NGS in non-small cell lung cancer: What changes in the biomarker era?].
Hamard C; Mignard X; Pecuchet N; Mathiot N; Blons H; Laurent-Puig P; Leroy K; Lupo A; Chapron J; Giraud F; Arrondeau J; Goldwasser F; Alifano M; Damotte D; Wislez M
Rev Pneumol Clin; 2018 Oct; 74(5):327-338. PubMed ID: 30343945
[TBL] [Abstract][Full Text] [Related]
32. Increased expression of SOX4 is a biomarker for malignant status and poor prognosis in patients with non-small cell lung cancer.
Wang D; Hao T; Pan Y; Qian X; Zhou D
Mol Cell Biochem; 2015 Apr; 402(1-2):75-82. PubMed ID: 25567207
[TBL] [Abstract][Full Text] [Related]
33. EUS-FNA and biomarkers for the staging of non-small cell lung cancer.
Al-Haddad M; Wallace MB
Endoscopy; 2006 Jun; 38 Suppl 1():S114-7. PubMed ID: 16802242
[No Abstract] [Full Text] [Related]
34. Development of a Protein Biomarker Panel to Detect Non-Small-Cell Lung Cancer in Korea.
Jung YJ; Katilius E; Ostroff RM; Kim Y; Seok M; Lee S; Jang S; Kim WS; Choi CM
Clin Lung Cancer; 2017 Mar; 18(2):e99-e107. PubMed ID: 27836219
[TBL] [Abstract][Full Text] [Related]
35. MicroRNA dysregulational synergistic network: discovering microRNA dysregulatory modules across subtypes in non-small cell lung cancers.
Tran N; Abhyankar V; Nguyen K; Weidanz J; Gao J
BMC Bioinformatics; 2018 Dec; 19(Suppl 20):504. PubMed ID: 30577741
[TBL] [Abstract][Full Text] [Related]
36. A multi-omic study reveals BTG2 as a reliable prognostic marker for early-stage non-small cell lung cancer.
Shen S; Zhang R; Guo Y; Loehrer E; Wei Y; Zhu Y; Yuan Q; Moran S; Fleischer T; Bjaanaes MM; Karlsson A; Planck M; Staaf J; Helland Å; Esteller M; Su L; Chen F; Christiani DC
Mol Oncol; 2018 Jun; 12(6):913-924. PubMed ID: 29656435
[TBL] [Abstract][Full Text] [Related]
37. Predictive and prognostic effect of CD133 and cancer-testis antigens in stage Ib-IIIA non-small cell lung cancer.
Su C; Xu Y; Li X; Ren S; Zhao C; Hou L; Ye Z; Zhou C
Int J Clin Exp Pathol; 2015; 8(5):5509-18. PubMed ID: 26191258
[TBL] [Abstract][Full Text] [Related]
38. [Diagnosis, prognosis, and prediction of non-small cell lung cancer. Importance of morphology, immunohistochemistry and molecular pathology].
Warth A
Pathologe; 2015 Nov; 36 Suppl 2():194-200. PubMed ID: 26391251
[TBL] [Abstract][Full Text] [Related]
39. Downregulation of GSDMD attenuates tumor proliferation via the intrinsic mitochondrial apoptotic pathway and inhibition of EGFR/Akt signaling and predicts a good prognosis in non‑small cell lung cancer.
Gao J; Qiu X; Xi G; Liu H; Zhang F; Lv T; Song Y
Oncol Rep; 2018 Oct; 40(4):1971-1984. PubMed ID: 30106450
[TBL] [Abstract][Full Text] [Related]
40. High PITX1 expression in lung adenocarcinoma patients is associated with DNA methylation and poor prognosis.
Song X; Zhao C; Jiang L; Lin S; Bi J; Wei Q; Yu L; Zhao L; Wei M
Pathol Res Pract; 2018 Dec; 214(12):2046-2053. PubMed ID: 30322808
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
